|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
17.06.26 - 14:06
|
Gero Reaches $34M in Equity Funding to Turn the Physics of Aging Into Medicines (Business Wire)
|
|
|
Following a Chugai (Roche Group) collaboration with up to $250M in milestones in addition to royalties, and inspired by mammals that defy the rules of aging, Gero uses physics-first AI and human longitudinal data to develop medicines that substantially slow aging and treat age-related diseases.SINGAPORE & SAN FRANCISCO--(BUSINESS WIRE)--#AI--Gero, which previously secured a collaboration with Chugai Pharmaceutical, a member of the Roche Group, including an upfront payment and up to $250M in milestones in addition to royalties, today announced $17M in new financing, bringing total equity funding to $34M.
Gero combines longitudinal human data, AI, and a physics-based aging framework for therapeutic target identification and drug design. Gero's approach was born from a crucial but underappreciated observation: nature has already achieved dramatic slowing of aging and extremely long healthy life in several complex mammals. While in humans the risk of death roughly doubles every eight years after early adulth...
|
|
|
|
|
|
|
|
|
|
|
20.04.26 - 10:00
|
Chugai Pharmaceutical Ends Trading Day Up 5.9% on Favorable Obesity Drug Data (AAStocks)
|
|
|
Chugai Pharmaceutical (4519.JP) closed the trading day at JPY8,844 today (20th), up 5.9% for the day.The company has granted Eli Lilly (LLY.US) the global development and commercialization rights for its obesity drug Orforglipron, which has also received approval for sale from the US Food and Drug Administration.Last Thursday (1......
|
|
|
30.03.26 - 09:36
|
Mitsubishi Electric Announces Director Candidates (Business Wire)
|
|
|
TOKYO--(BUSINESS WIRE)--Mitsubishi Electric Corporation (TOKYO: 6503) announced today that the candidates for Directors, who will be proposed for election at the Ordinary General Meeting of Shareholders scheduled in June 2026, were elected at the company's Nomination Committee meeting held earlier today.
Director Candidates (current positions)
Tatsuro Kosaka (Director (Senior Advisor, CHUGAI PHARMACEUTICAL CO., LTD.))
Hiroyuki Yanagi (Director)
Masako Egawa (Director (Chancellor, Seikei Gakuen))
Haruka Matsuyama (Director (Attorney-at-law (Partner, Hibiya Park Law Offices)))
Kunihito Minakawa (Director)
Peter D. Pedersen (Director (Executive Director, NELIS, a corporation engaging in specified non-profit activities))
Mieko Nakabayashi (Professor, Waseda University) [new candidate]
Kei Uruma (Director; Representative Executive Officer, President & CEO)
Atsuhiro Yabu (Director)
Noriyuki Takazawa (Director; Representative Executive Officer, Senior Vice President; CSO (in charge of Corporate Strategic Planni...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
